Last reviewed · How we verify

NCT01570010: CRC-NORDIET

The Norwegian Dietary Guidelines and Colorectal Cancer Survival Study

Active, enrolled NA Last updated 27 February 2026
What this trial tests

NA trial testing Norwegian food based dietary guidelines in Colorectal Cancer in 503 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 March 2012
Primary endpoint
31 December 2034
31 December 2040

Quick facts

Lead sponsorUniversity of Oslo
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment503
Start date1 March 2012
Primary completion31 December 2034
Estimated completion31 December 2040
Sites3 locations across Norway

Drugs / interventions tested

Conditions studied

Sponsor

University of Oslo

Who can join

Adults 50 to 80, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study is designed to gain a better understanding of the role of a healthy diet aimed at dampening inflammation and oxidative stress on long-term disease outcomes and survival in colorectal cancer patients. Since previous research on the role of diet for colorectal cancer survivors is limited, the study may be of great importance for this cancer population.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The Norwegian dietary guidelines and colorectal cancer survival (CRC-NORDIET) study: a food-based multicentre randomized controlled trial.
    Henriksen HB, Ræder H, Bøhn SK, Paur I, et al · · 2017 · cited 27× · PMID 28137255 · DOI 10.1186/s12885-017-3072-4
  2. Relative validity of a short food frequency questionnaire assessing adherence to the Norwegian dietary guidelines among colorectal cancer patients.
    Henriksen HB, Carlsen MH, Paur I, Berntsen S, et al · · 2018 · cited 23× · PMID 29545734 · DOI 10.29219/fnr.v62.1306
  3. Validation of two short questionnaires assessing physical activity in colorectal cancer patients.
    Henriksen HB, Berntsen S, Paur I, Zucknick M, et al · · 2018 · cited 12× · PMID 29854408 · DOI 10.1186/s13102-018-0096-2
  4. Associations of the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) cancer prevention recommendations with stages of colorectal carcinogenesis.
    Kvaerner AS, Andersen AR, Henriksen HB, Knudsen MD, et al · · 2023 · cited 5× · PMID 37212529 · DOI 10.1002/cam4.6119
  5. How many days of continuous physical activity monitoring reliably represent time in different intensities in cancer survivors.
    Western B, Demmelmaier I, Vistad I, Hansen BH, et al · · 2023 · cited 4× · PMID 37093874 · DOI 10.1371/journal.pone.0284881
  6. Plant-based diet and oxidative stress-induced DNA damage in post-surgery colorectal cancer patients: Results from a randomized controlled trial.
    Nordengen AL, Krutto A, Kværner AS, Alavi DT, et al · · 2025 · cited 2× · PMID 40180023 · DOI 10.1016/j.freeradbiomed.2025.03.047
  7. Predictive equations commonly used in the clinic underestimate resting energy expenditure compared with whole-room indirect calorimetry in colorectal cancer survivors.
    Eklo RR, Alavi DT, Konglevoll DM, Kolle Å, et al · · 2026 · PMID 41611086 · DOI 10.1016/j.ajcnut.2026.101209
  8. Spillover effect of a dietary intervention on physical activity in a randomized controlled trial with colorectal cancer patients.
    Henriksen HB, Kolle Å, Stenling A, Paur I, et al · · 2025 · PMID 40346639 · DOI 10.1186/s12966-025-01757-0

Verify or expand the search:

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

Other University of Oslo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01570010.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing